Remove 2018 Remove Communication Remove Pharmaceutical Companies
article thumbnail

Time to change the channel? The future for customer engagement models

pharmaphorum

The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceutical company engagement during the crisis. The answer was yes.

article thumbnail

Valuable virtual tools to keep HCPs informed

pharmaphorum

Use of these platforms was however already trending up before the crisis, and there’s every sign demand will stay high from now on, according to Sjors van den Camp, commercial director at Online Seminar – a company whose heritage in this sector goes back more than a decade. The crisis that changed everything.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Navigating Life Sciences Construction in California

ISPE

It's no wonder that global pharmaceutical companies are increasingly sourcing innovation through alliances and partnerships with their peers in California. California accounted for 15–18% of patents granted in core life sciences applications between 2018 and 2022.

article thumbnail

Why pharma needs a revolution in culture

pharmaphorum

Critically, the risks of conduct related issues that weighed heavily on the reputation of pharmaceutical companies prior to COVID-19 have not gone away, for example the minimising of side effects, price manipulation, or healthcare system fraud amongst others. Compliance systems by themselves are not enough.

article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceutical companies to publish their prices in a password protected site on HRSA's website. Four of the five staffers originally involved in the investigation now work for or lobby for the pharmaceutical industry.

article thumbnail

How digital pathways are changing healthcare

pharmaphorum

Improvements in the quality and flow of data between primary care, secondary care and the patient leads to an infinitely better overall level of communication,” says Parkes, “which in turn leads to more engaged and educated patients. “We In 2018, he co-founded Ampersand Health and developed My IBD Care. About the interviewees.

article thumbnail

Breaking into the global pharmaceutical market

pharmaphorum

I think the most important thing is making a good team and also good communication within that team is very important. RudaCure is a South Korea based clinical stage bio-pharmaceutical startup founded in 2018. Everyone in our team is very valuable,” he said. “I Moving to the global stage. About RudaCure.